Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)

EGX: CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	246.11	246.11	97.09	165.74	124.3	109.14
Depreciation & Amortization	19.84	19.84	15.94	-	-	0.65
Other Amortization	0.01	0.01	0.01	-	-	-
Other Operating Activities	-3.08	-3.08	-24.52	-113.92	37.95	-131.75
Operating Cash Flow	262.89	262.89	88.53	51.83	162.25	-21.96
Operating Cash Flow Growth	342.34%	196.96%	70.82%	-68.06%	-	-
Capital Expenditures	-243.54	-243.54	-79.07	-17.31	-23.68	-8.34
Sale of Property, Plant & Equipment	-	-	0.08	0	0.04	-
Investment in Securities	-0.84	-0.84	-	15.86	-14.11	14.47
Other Investing Activities	12.8	12.8	2.85	4.94	2.62	2.28
Investing Cash Flow	-231.58	-231.58	-76.14	3.49	-35.13	8.41
Long-Term Debt Issued	133.88	133.88	144.31	-	-	-
Long-Term Debt Repaid	-50.76	-50.76	-28.36	-	-	-
Net Debt Issued (Repaid)	83.12	83.12	115.95	-	-	-
Common Dividends Paid	-85.53	-85.53	-100.82	-75.2	-77.73	-54.95
Financing Cash Flow	-2.41	-2.41	15.13	-75.2	-77.73	-54.95
Net Cash Flow	28.9	28.9	27.51	-19.89	49.39	-68.5
Free Cash Flow	19.35	19.35	9.45	34.52	138.57	-30.3
Free Cash Flow Growth	-	104.69%	-72.61%	-75.09%	-	-
Free Cash Flow Margin	1.42%	1.42%	0.94%	3.10%	13.05%	-3.00%
Free Cash Flow Per Share	1.30	1.30	0.63	2.31	9.28	-2.03
Cash Interest Paid	20.21	20.21	5.85	-	-	-
Cash Income Tax Paid	45.89	45.89	73.12	51.33	36.22	36.35
Levered Free Cash Flow	-55.03	-55.03	57.94	-20.17	97.35	-51.72
Unlevered Free Cash Flow	-43.19	-43.19	60.12	-20.17	97.35	-51.72
Change in Net Working Capital	-1.94	-1.94	-75.27	122.91	-23.32	130.76

Source: S&P Capital IQ. Standard template. Financial Sources.